September 19, 2023 03:44 PM EDT

Chinese imports of common cancer drug run dry, FDA says

Anna Brown

News Reporter

China’s Qilu Pharmaceutical has distributed all of the chemotherapy cisplatin that was imported as a result of the shortage of the common cancer drug. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Chinese imports of common cancer drug run dry, FDA says

Anna Brown

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Roche, Genentech end anti-tau Alzheimer’s drug collaboration with UCB

Novo declares Phase 3 cardiac outcomes trial win for oral GLP-1

Starboard takes activist stake in J&J consumer spinout Kenvue

Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale

AvenCell gets $112M to build switchable CAR-T therapies for ‘the last frontier’ of blood cancers

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Chi­nese im­ports of com­mon can­cer drug run dry, FDA says

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Chinese imports of common cancer drug run dry, FDA says